| P50 | author | Jean-Yves Reginster | Q29839787 |
| | Olivier Bruyère | Q29839802 |
| P2093 | author name string | Pierre Damas | |
| | Etienne Cavalier | |
| | Anne-Françoise Rousseau | |
| P2860 | cites work | Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline | Q22306207 |
| | Why the IOM recommendations for vitamin D are deficient | Q34165912 |
| | Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference | Q34219343 |
| | A pilot study of change in fracture risk in patients with acute respiratory distress syndrome. | Q35545225 |
| | Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study | Q35595242 |
| | Physical complications in acute lung injury survivors: a two-year longitudinal prospective study | Q37646839 |
| | Intensive care unit-acquired weakness | Q37667719 |
| | The incidence of falls in intensive care survivors | Q37904276 |
| | Vitamin D metabolism and deficiency in critical illness | Q37933821 |
| | The association between critical illness and changes in bone turnover in adults: a systematic review | Q38209896 |
| | Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial | Q38423032 |
| | The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. | Q40828040 |
| | INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS. | Q40885186 |
| | Preadmission Bisphosphonate and Mortality in Critically Ill Patients. | Q40968462 |
| | Changes in Bone Mineral Density in the Year after Critical Illness | Q41130796 |
| | Bone - a casualty of ICU survival? | Q42424467 |
| | Skeletal morbidity among survivors of critical illness. | Q44605763 |
| | Critical care and vitamin D status assessment: what about immunoassays and calculated free 25OH-D? | Q47844097 |
| | Functional disability 5 years after acute respiratory distress syndrome | Q48696705 |
| | A FRAX® model for the assessment of fracture probability in Belgium | Q50143115 |
| | Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness. | Q51487384 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone fracture | Q68833 |
| | intensive care unit | Q5094647 |
| P577 | publication date | 2017-07-10 | |
| P1433 | published in | Calcified Tissue International | Q5018771 |
| P1476 | title | Occurrence of Clinical Bone Fracture Following a Prolonged Stay in Intensive Care Unit: A Retrospective Controlled Study | |